Skip to main content
OpenTrials

Clinical trial condition

Blood-Borne Infections

Explore clinical trials studying Blood-Borne Infections. Study availability and eligibility vary by location and protocol.

8,277 public trials 443 recruiting studies
Refine in advanced search Browse all conditions

Blood-Borne Infections trial results

Completed

Comparison of Sofosbuvir/Velpatasvir Fixed Dose Combination for 12 Weeks With Sofosbuvir and Ribavirin for 12 Weeks in Adults With Chronic Genotype 2 HCV Infection

NCT02220998

Conditions
Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +12 more
Locations
  • Long Beach, California, United States
  • Los Angeles, California, United States
  • Los Angeles, California, United States
  • Los Angeles, California, United States
View all 51 locations
View Trial Details
Completed

Safety and Efficacy of Sofosbuvir Plus Velpatasvir With or Without Ribavirin in Treatment-experienced Subjects With Chronic HCV Infection

NCT01909804

Conditions
Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +8 more
Locations
  • Long Beach, California, United States
  • Los Angeles, California, United States
  • Pasadena, California, United States
  • San Diego, California, United States
View all 49 locations
View Trial Details
Completed

Sofosbuvir/Velpatasvir Fixed-Dose Combination and Ribavirin for 12 or 24 Weeks in Participants With Chronic Genotype 1 or 2 Hepatitis C Virus Infection Who Have Previously Failed a Direct-Acting Antiviral-Containing Regimen

NCT02822794

Conditions
Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +9 more
Locations
  • Ehime, Japan
  • Hiroshima, Japan
  • Ichikawa-shi, Japan
  • Iruma-gun, Japan
View all 18 locations
View Trial Details
Completed

Efficacy, Safety, and Tolerability of Ledipasvir/Sofosbuvir (LDV/SOF) Treatment for HIV/HCV Co-infected Participants Who Switch to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (E/C/F/TAF) or Emtricitabine/Rilpivirine/Tenofovir Alafenamide (F/R/TAF) Prior to LDV/SOF HCV Treatment

NCT02707601

Conditions
Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +10 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Spectrum Medical Group Phoenix, Arizona, United States
  • Mills Clinical Research Los Angeles, California, United States
  • Peter J Ruane MD Inc Los Angeles, California, United States
View all 43 locations
View Trial Details
Completed

HIV Attachment Inhibitor to Treat Human Immunodeficiency Virus 1 (HIV-1) Infections

NCT01384734

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
Locations
  • GSK Investigational Site San Francisco, California, United States
  • GSK Investigational Site San Francisco, California, United States
  • GSK Investigational Site Washington D.C., District of Columbia, United States
  • GSK Investigational Site Coral Gables, Florida, United States
View all 54 locations
View Trial Details

Related conditions